Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Eli Lilly & Co on Tuesday said it expects to report lower fourth quarter revenue than the bottom of a range it had pr ...
...
Popular diabetes and obesity drugs by Novo Nordisk AS and Eli Lilly & Co could also help to protect the kidneys, a ne ...
Eli Lilly & Co on Wednesday reported strong revenue growth in the third quarter and a return to profit, as it develop ...
Eli Lilly & Co on Monday announced it has appointed Lucas Montarce as chief financial officer with immediate effect. ...
Eli Lilly & Co on Thursday raised annual guidance once again, as it reported double-digit growth in the second quarte ...
Patients taking Eli Lilly & Co's new drug Mounjaro achieved significantly greater weight loss than those on Novo Nord ...
Alphabet Inc on Wednesday said Anat Ashkenazi will become the company's new chief financial officer from the end of J ...
Eli Lilly & Co announced on Wednesday that it has come to an agreement with Totality Medispa over the latter's claim ...
Eli Lilly & Co on Tuesday lifted its full-year sales outlook as it reported increased demand for its weight-loss and ...
Eli Lilly & Co's highly anticipated Alzheimer's drug has been held back for further review by regulators, the US phar ...
Eli Lilly & Co on Tuesday reported higher fourth-quarter sales, with sales of recently-launched weight loss drugs hel ...
A weight loss drug newly approved in a four-dose injection pen format by the Medicines & Healthcare products Regulato ...
- Indianapolis, Indiana-based pharmaceutical company - Subsidiary Akouos Inc reports positive initial clinical results ...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관